Associated Papers
Characterization of prevalent genetic variants in the Estonian Biobank body-mass index GWAS.
Abner E et al.
Nature Communications, 2025
41062462 (PubMed )
Supplement: 41467_2025_64006_MOESM6_ESM.xlsx › Figure1a
Indicators of HSV1 Infection, ECM-Receptor Interaction, and Chromatin Modulation in a Nuclear Family with Schizophrenia.
Huang YC et al.
Journal of Personalized Medicine, 2023
37763159 (PubMed )
Supplement: jpm-13-01392-s001.zip › Supplementary_Table_S3.xlsx › Variants
Conditional deletion of Neurexin-2 alters neuronal network activity in hippocampal circuitries and leads to spontaneous seizures.
Haile MT et al.
Translational Psychiatry, 2023
36941261 (PubMed )
Supplement: 41398_2023_2394_MOESM5_ESM.xlsx › Sheet1
Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder.
Khoja S et al.
Frontiers in Molecular Neuroscience, 2023
36923655 (PubMed )
Supplement: Table_1.XLSX › NRXN2
Genomic selection signatures in autism spectrum disorder identifies cognitive genomic tradeoff and its relevance in paradoxical phenotypes of deficits versus potentialities.
Prakash A et al.
Scientific Reports, 2021
33986442 (PubMed )
Supplement: 41598_2021_89798_MOESM3_ESM.xlsx › Table_S1
Multiple Rare Risk Coding Variants in Postsynaptic Density-Related Genes Associated With Schizophrenia Susceptibility.
Hu TM et al.
Frontiers in Genetics, 2020
Neurexin gene family variants as risk factors for autism spectrum disorder.
Wang J et al.
Autism Research : Official Journal of the International Society for Autism Research, 2018
Select a paper to view details